McGuireWoods has a powerful presence in Dallas. Since the office launched in 2014, it has grown quickly to more than 40 lawyers known throughout Texas, the Southwest and the United States for high-quality service and years of experience in private equity, debt finance, labor and employment, financial services litigation, intellectual property and healthcare.
Private Equity: We counsel institutional and individual investors, leveraging market insight in private equity, mezzanine finance, junior capital, hedge funds, fund formation, venture capital, and M&A. Dallas is the site for the firm’s national Independent Sponsor Conference, the only annual event of its scale open exclusively to independent sponsors and capital providers, and Emerging Manager Conference, tailored to limited partners and emerging managers.
Debt Finance: McGuireWoods has one of the largest debt finance practices in the U.S. Topping the rankings for syndicated debt financings, our team placed fourth in deal count and seventh in dollar volume in Thomson Reuters’ year-end league tables.
Labor and Employment: Dallas L&E lawyers assist with wage and hour claims; class actions; litigation involving discrimination, retaliation, harassment, disability and leave; and enforcement of employment, noncompete and confidentiality agreements.
Financial Services Litigation: We help clients succeed in an era of unprecedented challenges. Our Dallas lawyers illustrate the experience that has earned McGuireWoods recognition from U.S. News-Best Lawyers as “Law Firm of the Year” for banking and finance litigation.
Intellectual Property: Dallas lawyers manage international patent portfolios and help clients develop, protect and exploit commercially valuable ideas and information. We litigate patent cases before the U.S. International Trade Commission and in U.S. district courts, including the Eastern District of Texas, a hot-spot jurisdiction.
Healthcare: Our lawyers focus on acquisitions, divestitures, affiliations, joint ventures and other strategic transactions, with a unique perspective on issues facing for-profit and not-for-profit healthcare compaHTMLnies.
